ProCE Banner Activity

An Online Tool Featuring Expert Treatment Recommendations for Adults With B-Cell ALL

Clinical Thought
Are you interested in seeing treatment recommendations for adult patients with B-cell ALL from 5 experts? In this commentary, Jae H. Park, MD, describes an online Interactive Decision Support Tool that provides expert guidance to clinicians on treatment options for adult patients with B-cell ALL.

Released: May 15, 2020

Expiration: May 14, 2021

Share

Faculty

Jae H. Park

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Jazz Pharmaceuticals, Inc.

Pfizer, Inc.

Faculty Disclosure

Primary Author

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

Jae H. Park, MD, has disclosed that he has received consulting fees from Allogene, Amgen, AstraZeneca, Autolus, GlaxoSmithKline, Incyte, Kite, Novartis, and Takeda.